SEO URLwww.firestrike.ai/deals/metsera-pfizer-acquisition-2026-1
acquisitionAnnounced · Feb 3, 2026PharmaceuticalsSource · CredibleArticle · Factual
Pfizer acquires Metsera
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$7.3B
Target
Metsera
NASDAQ: MTSR · New York City, New York
Acquirer
Pfizer
Full Acquisition
Status
Announced
Pfizer agreed to acquire Metsera. Reported deal value: $7.3B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: New York City, New York, United States.
This page summarizes publicly available information about the transaction as of 2026-02-03. Figures and status may change as filings and press coverage update.
An experimental obesity shot Pfizer got through a buyout of Metsera helped enrollees in a mid-stage trial lose significantly more weight than a placebo, spurring up to an 11% reduction over 28 weeks using a regimen that switched from a weekly to monthly dose after 12 weeks
Deal timeline
Announced
Feb 3, 2026 · biopharmadive.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $7.3B. Figures and status may change as sources update.
Sources: biopharmadive.com · Primary article · FireStrike proprietary index